๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Diclofenac sodium - Medicines in Ireland

31 authorised products containing Diclofenac sodium, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 31 authorised medicines
MedicineActive substanceLicence holderStatus
Arthrotec 50 modified-release tablets
PA0822/112/001
Diclofenac sodium, Misoprostol Pfizer Healthcare Ireland Unlimited Company Marketed
Arthrotec 50 modified-release tablets
PPA0465/114/001
Misoprostol, Diclofenac sodium PCO Manufacturing Ltd. โ€”
Arthrotec 75 modified-release tablets
PA0822/112/002
Diclofenac sodium, Lactose monohydrate, Misoprostol Pfizer Healthcare Ireland Unlimited Company Marketed
Arthrotec 75 modified-release tablets
PPA0465/114/002
Diclofenac sodium, Misoprostol PCO Manufacturing Ltd. โ€”
Arthrotec 75 modified-release tablets
PPA1463/159/001
Diclofenac sodium, Misoprostol IMED Healthcare Ltd., โ€”
Diclac 1% w/w Gel
PA0711/009/002
Diclofenac sodium Rowex Limited, Marketed
Diclac 100mg Suppositories
PA0711/009/009
Diclofenac sodium Rowex Limited, Marketed
Diclac 25 mg/ml Solution for Injection 3 ml Ampoule
PA0711/009/010
Diclofenac sodium Rowex Limited, Not marketed
Diclac 50 mg Gastro-resistant Tablets
PA0711/009/008
Diclofenac sodium Rowex Limited, Marketed
Diclac 75 mg Prolonged-release Tablet
PA0711/009/003
Diclofenac sodium Rowex Limited, Marketed
Diclac Relief 1% w/w Gel
PA0711/009/005
Diclofenac sodium Rowex Limited, Marketed
Diclac Retard 100 mg Prolonged-release Tablets
PA0711/009/006
Diclofenac sodium Rowex Limited, Marketed
Diclofenac Liderlens 40 mg/ml cutaneous spray solution
PA2090/004/001
Diclofenac sodium Farmalider S.A. Not marketed
Difene 1% w/w Gel
PA2256/001/005
Diclofenac sodium Glenwood GmbH Marketed
Difene 100 mg Dual Release Capsules
PA2256/001/004
Diclofenac sodium Glenwood GmbH Marketed
Difene 100mg Suppositories
PA2256/001/006
Diclofenac sodium Glenwood GmbH Not marketed
Difene 25mg Capsules
PA2256/001/001
Diclofenac sodium Glenwood GmbH Marketed
Difene 50mg Capsules
PA2256/001/002
Diclofenac sodium Glenwood GmbH Marketed
Difene 75 mg Dual Release Capsules
PA2256/001/003
Diclofenac sodium Glenwood GmbH Marketed
Difene Spray Gel 4% w/w Cutaneous Spray, Solution
PA2256/001/007
Diclofenac sodium Glenwood GmbH Marketed
Itami 140 mg medicated plaster
PA0814/002/001
Diclofenac sodium Fidia Farmaceutici S.p.A. Not marketed
Solaraze 3% gel
PA0968/004/001
Diclofenac sodium Almirall, S.A. Marketed
Solaraze 3% gel
PPA0465/488/001
Diclofenac sodium PCO Manufacturing Ltd. โ€”
Solaraze 3% gel
PPA1463/205/001
Diclofenac sodium IMED Healthcare Ltd., โ€”
Voltarol 50 mg Gastro-Resistant Tablets
PA0896/034/001
Diclofenac sodium Novartis Ireland Limited Marketed
Voltarol Emulgel Extra Strength 2% w/w gel
PA0678/140/003
Diclofenac sodium Haleon Ireland Limited Not marketed
Voltarol Emulgel Extra Strength 2% w/w gel
PPA1463/221/001
Diclofenac sodium IMED Healthcare Ltd., โ€”
Voltarol Muscle & Joint Pain Relief 140 mg medicated plaster
PA0678/140/004
Diclofenac sodium Haleon Ireland Limited Not marketed
Voltarol Ophtha Multidose 1mg/ml Eye Drops Solution
PA1107/009/002
Diclofenac sodium Laboratoires Thea Not marketed
Voltarol Retard 100 mg Film-coated Prolonged Release Tablets
PA0896/034/002
Diclofenac sodium Novartis Ireland Limited Marketed
Voltarol Retard 75 mg Film-coated Prolonged-release Tablets
PA0896/034/003
Diclofenac sodium Novartis Ireland Limited Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.